These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18193927)

  • 21. [Characteristics and indications of topiramate].
    Nieto-Barrera M
    Rev Neurol; 2002 Sep; 35 Suppl 1():S88-95. PubMed ID: 12373660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topiramate titration to response: analysis of individualized therapy study (TRAITS).
    Dodson WE; Kamin M; Kraut L; Olson WH; Wu SC
    Ann Pharmacother; 2003 May; 37(5):615-20. PubMed ID: 12708932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group.
    Glauser TA; Levisohn PM; Ritter F; Sachdeo RC
    Epilepsia; 2000; 41(S1):86-90. PubMed ID: 10768308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The value of topiramate used with conventional schemes as an adjunctive therapy in the treatment of Lennox-Gastaut syndrome].
    Alva-Moncayo E; Ruiz-Ruiz A
    Rev Neurol; 2003 Mar 1-15; 36(5):453-7. PubMed ID: 12640599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term efficacy and tolerance of topiramate in 44 children with resistant epilepsy].
    Herranz JL; Arteaga R
    Rev Neurol; 1999 Jun 1-15; 28(11):1052-6. PubMed ID: 10390772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topiramate monotherapy in epilepsy and migraine prevention.
    Silberstein SD; Ben-Menachem E; Shank RP; Wiegand F
    Clin Ther; 2005 Feb; 27(2):154-65. PubMed ID: 15811478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topiramate: its pharmacological properties and therapeutic efficacy in epilepsy.
    Latini G; Verrotti A; Manco R; Scardapane A; Del Vecchio A; Chiarelli F
    Mini Rev Med Chem; 2008 Jan; 8(1):10-23. PubMed ID: 18220981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of generalized tonic-clonic seizures in refractory focal epilepsy: a meta-analysis.
    Hemery C; Ryvlin P; Rheims S
    Epilepsia; 2014 Nov; 55(11):1789-99. PubMed ID: 25182978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pharmacological and clinical review on topiramate, a new antiepileptic drug.
    Perucca E
    Pharmacol Res; 1997 Apr; 35(4):241-56. PubMed ID: 9264038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents.
    Glauser TA; Dlugos DJ; Dodson WE; Grinspan A; Wang S; Wu SC;
    J Child Neurol; 2007 Jun; 22(6):693-9. PubMed ID: 17641254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Topiramate, a new antiepileptic drug].
    Herranz JL
    Rev Neurol; 1997 Aug; 25(144):1221-5. PubMed ID: 9340155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic interactions of topiramate.
    Bialer M; Doose DR; Murthy B; Curtin C; Wang SS; Twyman RE; Schwabe S
    Clin Pharmacokinet; 2004; 43(12):763-80. PubMed ID: 15355124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.
    Grosso S; Franzoni E; Iannetti P; Incorpora G; Cardinali C; Toldo I; Verrotti A; Caterina Moscano F; Lo Faro V; Mazzone L; Zamponi N; Boniver C; Spalice A; Parisi P; Morgese G; Balestri P
    J Child Neurol; 2005 Nov; 20(11):893-7. PubMed ID: 16417859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cotherapy reduction on tolerability of epilepsy add-on therapy: a randomized controlled trial.
    Naritoku DK; Hulihan JF; Schwarzman LK; Kamin M; Olson WH
    Ann Pharmacother; 2005 Mar; 39(3):418-23. PubMed ID: 15701778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities.
    Singh BK; White-Scott S
    Seizure; 2002 Jan; 11(1):47-50. PubMed ID: 11888260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Topamax in the treatment of epilepsy].
    Gromov SA; Lipatova LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(5):28-31. PubMed ID: 15952537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical efficacy and tolerability of topamax in combined therapy of epilepsy].
    Mukhin KIu; Petrukhin AS; Mironov MB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(3):28-33. PubMed ID: 12830503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
    Hunt S; Russell A; Smithson WH; Parsons L; Robertson I; Waddell R; Irwin B; Morrison PJ; Morrow J; Craig J;
    Neurology; 2008 Jul; 71(4):272-6. PubMed ID: 18645165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.